EVerZom Overview

  • Founded
  • 2019

  • Status
  • Private

  • Employees
  • 12

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $950K

  • Investors
  • 8

EVerZom General Information


Operator of a nanomedicine biotech company designed to create extracellular vesicles. The company's extracellular vesicles have protective and reparative properties representing an important therapeutic tool, enabling healthcare professionals to use them to overcome the failure of an organ, restoring its function and homeostasis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 45 Rue des Saints-Pères
  • 75006 Paris
  • France

EVerZom Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EVerZom Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 03-Dec-2020 $950K 00000 Completed Generating Revenue
2. Grant 13-Dec-2019 000.00 Completed Startup
1. Accelerator/Incubator 01-Jul-2019 Completed Startup
To view EVerZom’s complete valuation and funding history, request access »

EVerZom Executive Team (6)

Name Title Board Seat Contact Info
Jeanne Volatron Co-Founder, Chief Executive Officer & Président
Nicolas Rousseau Co-Founder, CCO & Directeur Général
Claire Wilhelm Co-Founder & Scientific Board Member
Max Piffoux Ph.D Co-Founder & Chief Technology Officer
Amanda Brun Ph.D Co-Founder, CSO & Scientific Board Member
You’re viewing 5 of 6 executive team members. Get the full list »

EVerZom Board Members (2)

Name Representing Role Since
Amanda Brun Ph.D Self Co-Founder, CSO & Scientific Board Member 000 0000
Claire Wilhelm EVerZom Co-Founder & Scientific Board Member 000 0000
To view EVerZom’s complete board members history, request access »

EVerZom Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EVerZom Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
d'lle de France Other Minority 000 0000 000000 0
Erganeo Venture Capital Minority 000 0000 000000 0
Innov'Up Leader Pia Corporation Minority 000 0000 000000 0
La French Tech Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »